Borui Pharmaceutical's Actual Controller Released on Bail Pending Trial for Securities Market Manipulation
36氪获悉，博瑞医药公告，公司实际控制人袁建栋因涉嫌操纵证券市场案，被苏州市公安局出具《取保候审决定书》，期限自2026年6月18日起算。袁建栋目前担任董事长兼总经理，并代行财务总监、董事会秘书职责，公司日常经营由各职能部门负责，该事项不涉及公司股票，不会对公司日常生产经营活动产生影响。公司将尽快于一个月内补选财务总监、董事会秘书，并及时履行信息披露义务。
Yuan Jiandong, the actual controller of Borui Pharmaceutical, has been released on bail pending trial due to alleged involvement in securities market manipulation. Yuan Jiandong currently serves as Chairman and General Manager, also acting as CFO and Board Secretary. The company assures that its daily operations will continue unaffected, managed by its functional departments, and plans to appoint replacements for the CFO and Board Secretary roles within a month.
The release on bail of Borui Pharmaceutical's actual controller raises concerns about corporate governance and market integrity, pending the outcome of the manipulation investigation.
📌 Kaynak
Bu haber XML kaynağından derlenmiştir. Tamamı için orijinal habere gidin.
Orijinal haberi oku →